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PLASMA levels of endotoxin and various cytokines were
assessed in 70 patients with gastrointestinal tract perfora-
tion. Sepsis developed in 29 of them, and eight of these
(27.6%) had on admission endotoxin levels higher than
9.8 pg ml-1. The clinical outcome correlated with the level
of tumour necrosis factor (TNFz), rather than with the
endotoxin level. The high interleukin 6 (IL-6) level was
shown in septic patients and no correlation was observed
between the IL-6 level and the clinical outcome. Plasma
TNF levels tended to change independently from en-
dotoxin levels, suggesting that TNF may have been
locally produced in inflammatory lesions.
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Introduction
Diffuse peritonitis occurring after perforation of
the gastrointestinal tract is associated with serious
complications such as sepsis, septic shock, dis-
seminated intravascular coagulation (DIC), adult
respiratory disease (ARDS), and multiple organ
failure (MOF). Endotoxin derived from the cell
walls of gram-negative bacteria has traditionally
been believed to be responsible for such complica-
tions. However, recent attention has been paid to
the various cytokines, which may play a significant
role as mediators in the induction of such patholog-
ical conditions.
1-3
We monitored plasma endotoxin and cytokine
levels in patients with gastrointestinal tract perfora-
tion in whom blood could be collected from the
earliest stage of the disease.
Materials and Methods
Patients: This study was performed in a total 70
patients with gastrointestinal perforation (excluding
injury and appendicitis) who were admitted to our
centre in the 3 year period from October 1987 to
September 1990, and in whom blood collection was
possible from the earliest stage after perforation.
There were 45 cases of gastroduodenal perforation,
twelve cases of small bowel perforation, and 13
cases of colonic perforation. Patients without sepsis
were classified as group A, those who developed
sepsis and survived formed group B, and those who
developed sepsis and died were placed in group C.
The diagnosis of sepsis was based on clear detec-
tion of focus of infection, positive blood culture,
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temperature higher than 38.5C or lower than
35.5C, or a white blood cell count more than
15 000 or less than 3 000.
Blood collection" Blood samples were collected on
admission and every day thereafter. When any
serious clinical change, including shock, DIC,
ARDS, and MOF, arose in the patients, blood was
collected about every 2-3 h. Blood was collected
into heparinized containers and centrifuged at 3 000
rpm for 40 s. The plasma samples thus obtained
(PRP) were stored at --80C until required for
analysis.
Measurement of endotoxin and cytokines" Endotoxin levels
were measured using the endotoxin-specific En-
dospecy test (Seikagaku Corporation, Tokyo,
Japan).
4 The new PCA method5’6 that we devised
ourselves was used for the pretreatment of plasma
samples. The normal range of plasma endotoxin
levels is below 9.8 pg m
-1 with this assay.
Plasma was diluted to a two-fold volume, then
TNFcz and IL-6 levels were measured with ELISA
(Genzyme MA, USA). The detection limits
for TNF and IL-6 were 0.024 ngrn1-1 and
0.3 ng ml-1, respectively.
Statistical analysis" Data are expressed as the
mean -F SD. Statistical analysis was performed with
the two-tailed Wilcoxon rank-sum test for unpaired
data, and the level of significance was set at
p < 0.05.
Results
The endotoxin level exceeded 9.8 pg m1-1 in
eleven of the 70 patients with gastrointestinal
Mediators of Inflammation Vol 1992 45S. Endo et al.
200
150
100
20
10
0
Sepsis(-)
n=41
Group A
--p<0.01--
p<0.01
oo
Survivors
O0
00
Nonsurvivors
n =14 n =15
Sepsis +
B C
FIG. 1. Plasma endotoxin levels in groups A, B, and C. The normal plasma
endotoxin level is below 9.8 pg m1-1
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FIG. 2. Plasma TNF levels in groups A, B, and C. The detection limit of
TNF0( is 0.024 ng m1-1
perforation (15.7%) (Fig. 1). Sepsis occurred in 29
patients, and eight of them had an endotoxin level
higher than normal (27.6%). The eleven patients
with abnormally raised endotoxin levels comprised
three were in group A (3/41; 7.3%), four in group B
(4/14; 28.6%), and four in group C (4/15, 26.7%).
The mean endotoxin level was significantly higher
in group B and C than in group A.
The septic patients comprised nine cases of
gastrointestinal perforation, another nine of small
bowel intestinal perforation, and eleven cases of
colonic perforation. The septic patients who had an
endotoxin level exceeding 9.8 pg m1-1 included one
of the nine cases of gastroduodenal perforation
(11.1%), two of the nine cases of small bowel
intestinal perforation (22.2%), and five of the eleven
cases of colonic perforation (45.5%). Thus, the
incidence of abnormal endotoxin levels was
significantly higher in the patients with colonic
perforation than in those with perforation at other
gastrointestinal sites.
There was no significant difference in the
incidence of abnormal endotoxin levels between
groups B and C.
The TNF0c level exceeded the detection limit in
9/41 patients in group A (22.0%), 8/14 patients in
group B (57.1%), and all 15 patients in group C
(100%). The mean TNF0c level was significantly
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higher in group B than in group A, and also
significantly higher in group C than in group B
(Fig. 2).
The IL-6 level exceeded the detection limit in
7/41 patients in group A (17.1%), 12/14 patients in
group B (85.7%), and 13/15 patients in group C
(86.7%). The mean IL-6 level was significantly
higher in groups B and C than in group A, but
there was no significant difference between group
B and C (Fig. 3).
Discussion
It has generally been believed that diffuse
peritonitis due, to gastrointestinal tract perforation
is associated with various complications because of
the high plasma endotoxin levels present in such
patients. The previously available methods for
detecting endotoxin were not specific and false-
positive readings could be produced by various
substances, so that results obtained with them may
not have been accurate. The endospecy test is an
endotoxin-specific assay that was developed recent-
ly. However, a problem still remained with the
conventional method for treating plasma. With the
existing PCA method for the pretreatment of
plasma, only one eighth of the actual endotoxin
level was detected, because the precipitate producedEndotoxin and cytokines in perforation
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FIG. 3. Plasma IL-6 levels in groups A, B, and C. The detection limit of
IL-6 is 0.3 ng m1-1
during treatment and which contained a large
amount of endotoxin, was discarded, s’6 Thus, the
relationship between various pathological states and
plasma endotoxin levels could not be accurately de-
termined. We therefore devised a new PCA
methods’6 which allowed us to also measure the
endotoxin in the precipitate by melting the
precipitate obtained from plasma.
The incidence of endotoxemia shown in this
investigation was much lower than expected.
However, it appears to be appropriate that the
incidence of endotoxemia was higher in patients
with small bowel perforation than in those with
gastroduodenal perforation, and that it was higher
again in patients with colonic perforation than in
those with small bowel perforation. Comparison
between the survivors and those dying of bowel
perforation did not show any significant difference
in the incidence of high endotoxin levels or in the
mean endotoxin level. This finding is inconsistent
with the traditional concept that endotoxin is
closely related to the promotion of complications
after bowel perforation. To explain the low
incidence of endotoxemia in patients with diffuse
peritonitis arising from gastrointestinal perforation,
it could be presumed that bacterial invasion outside
the bowel is infrequent or that it produces
endotoxin levels below 9.8pgml-1 in most
cases. It may be also possible that the intestinal
barrier is so strong that endotoxemia does not
occur.
The TNF0 level following gastrointestinal
perforation was significantly higher in patients with
sepsis (groups B and C) than in those free from
septic complications (group A). Furthermore, the
TNF0 level in the septic patients who died (group
C) was significantly higher than that in the septic
patients who survived (group B). These results
suggested that TNF0 had a significant involvement
with the progression of disease after intestinal
perforation.
In the patients of groups B and C, no correlation
was shown between the plasma endotoxin and
TNF0 levels, and the plasma levels of these
substances changed independently of each other.
The possibility was thus suggested that TNF0 in
plasma is produced locally at the site of infection
due to induction by endotoxin or other stimulatory
substances.
Mozes et al.7 have reported that in the
experimental endotoxic shock, the TNF level rather
than the endotoxin level has an important role in
the prognosis.
IL-6 has various biological activities, e.g., it is a
major mediator of inflammation and can be detected
in various inflammatory responses. Especially in
sepsis or septic shock, IL-6 is thought to interact
with endotoxin, IL-1, and TNF, and to play a
significant role in various pathological changes.
These substances enhance the production of each
other via feedback loops and form a complex
cytokine network. In this study, the IL-6 level was
significantly higher in the septic patients (groups B
and C) than in the non-septic patients (group A),
suggesting the involvement of IL-6 in inflamma-
tion. IL-6 levels showed no significant difference
between the survivors (group B) and the patients
dying of sepsis (group C). Septic shock has
been reported in patients with high levels of both
IL-6 and IL-lfl.
1 The finding in this study
suggested that in patients with gastrointestinal
perforation, endotoxin and cytokines (which are
produced by inflammatory stimulation) both have
an extensive involvement in the course of disease
due to their complex interactions.
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